UBS Initiates Coverage on STAAR Surgical Company (STAA) with Sell

Market Context

STAAR Surgical Company operates in the Healthcare sector. The stock currently trades at $22.66 with a market capitalization of $1.2B. The stock has gained 23.5% over the past 52 weeks.

Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for STAAR Surgical Company.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for STAAR Surgical Company

Among the 10 most recent ratings: 5 Buy, 4 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jul 28, 2026	UBS	Sell	N/A
Jul 22, 2026	Wedbush	Outperform	N/A
Jul 16, 2026	Wedbush	Outperform	N/A
May 29, 2026	Wedbush	Outperform	N/A
May 15, 2026	Wells Fargo	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View STAA Stock Page